In line with the findings in our study, CDK1 is overexpressed in several cancer types, including laryngeal squamous cell carcinoma [23], lung cancer [24], HCC [25], epithelial ovarian cancer [26], and pancreatic ductal adenocarcinoma [27]. Here, CDK1 is linked to hepatocellular carcinoma.